FDA Issues Draft Guidance on Financial Disclosure by Clinical Investigators

The FDA financial disclosure regulations are designed to help uncover potential investigator bias that may arise due to financial ties between the investigator and the clinical trial sponsor.

Read "FDA issues draft guidance on financial disclosure by clinical investigators"  

Download PDF Share Back To Listing
Loading data